| Scalare Partners Holdings Limited (SCP) ORDINARY FULLY PAID |
Consumer Staple |
$5 |
General Meeting Notice of Meeting, Access Letter & Proxy
|
2 Jul 2026 9:23AM |
$0.050 |
$0.050 |
fallen by
0%
|
|
SCP - Price-sensitive ASX Announcement
Full Release
Key Points
- Scalare Partners Holdings Limited is holding a General Meeting on 4 August 2026.
- The meeting will be held at Automic Group, Level 5, 126 Phillip Street, Sydney, NSW 2000.
- Voting can be done in person or by proxy, with detailed instructions provided for online, postal, and in-person submissions.
- Convertible notes and options play a significant role in the meeting's agenda, affecting share dilution and shareholder equity.
- Shareholder dilution scenarios are extensively covered, with tables depicting various outcomes based on different conversion and option exercise scenarios.
- Shareholders are encouraged to monitor announcements on the ASX platform and the company's website.
- Detailed terms of convertible notes and agreements are included in several annexures.
- An Independent Calculation Report by In.Corp Audit & Assurance Pty Ltd is annexed to the meeting notice.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ziller Global Fund Active ETF (ZILR) ZILLER GLOBAL FUND ACTIVE ETF |
Financials |
$11 |
Updated Product Disclosure Statement
|
2 Jul 2026 9:22AM |
$4.780 |
$4.520 |
fallen by
5.44%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$10,679 |
NEM Announces Second Quarter 2026 Earnings Conference Call
|
2 Jul 2026 9:22AM |
$131.980 |
$134.960 |
risen by
2.26%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$318 |
Positive DEP HER2-Lu preclinical data support Phase 1 entry
|
2 Jul 2026 9:22AM |
$0.710 |
$0.755 |
risen by
6.34%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive preclinical data for DEP® HER2-Lu supports Phase 1 entry.
- Strong tumor uptake and low kidney accumulation observed.
- DEP® platform enhances radiopharmaceutical delivery.
- Statistically significant anti-tumor activity and survival benefit demonstrated.
- Phase 1 study planned for H2 CY2026 with FDA support.
- DEP® HER2-Lu targets HER2-positive cancers like gastric and gastro-oesophageal junction cancers.
- Potential to address unmet medical needs in HER2-positive cancer treatments.
- Investor webinar scheduled for 7 July 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$51 |
Sangdong Mine Transitions to Saleable Tungsten Production
|
2 Jul 2026 9:22AM |
$23.600 |
$21.680 |
fallen by
8.14%
|
|
| Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$23 |
Update on Progress at the Prodigy Gold Twin Bonanza Project
|
2 Jul 2026 9:21AM |
$0.064 |
$0.068 |
risen by
6.25%
|
|
| MRG Metals Limited (MRQ) ORDINARY FULLY PAID |
Materials |
$10 |
Garies REE Project - Significant Gallium Identified
|
2 Jul 2026 9:21AM |
$0.003 |
$0.004 |
risen by
16.67%
|
|
MRQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant gallium identified at Garies REE Project.
- Drilling focused on magnetite-hosted REE mineralization.
- Gallium concentrations found in pyrite and monazite.
- Geochemical and geophysical methods used for analysis.
- Project part of MRG's strategy to exploit REE potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$587 |
Update - Notification of buy-back - RG1
|
2 Jul 2026 9:20AM |
$2.400 |
$2.500 |
risen by
4.17%
|
|
| Stakk Limited (SKK) ORDINARY FULLY PAID |
Information Technology |
$81 |
Trading Halt
|
2 Jul 2026 9:20AM |
$0.026 |
$0.026 |
fallen by
0%
|
|
SKK - Price-sensitive ASX Announcement
Full Release
Key Points
- Stakk Limited (ASX: SKK) requested a trading halt.
- The trading halt is pending an announcement regarding a material acquisition and a capital raise.
- The halt will remain in place until the commencement of normal trading on 6 July 2026 or the release of the announcement.
- Stakk is a leading AI-native trust and decision infrastructure provider.
- Stakk serves over 215 banks, credit unions, and global enterprises in Australia and the United States.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$49 |
Neurizon Invites Investors to Melbourne Briefing
|
2 Jul 2026 9:20AM |
$0.060 |
$0.064 |
risen by
6.67%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$318 |
DEP radiopharmaceutical data supports patent application
|
2 Jul 2026 9:20AM |
$0.710 |
$0.755 |
risen by
6.34%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Starpharma filed a new patent application for its DEP® technology in radioligand therapy.
- DEP® platform shows improved biodistribution, better tumor uptake, and reduced off-target accumulation.
- The technology demonstrated consistent results across HER2, PSMA, and EGFR oncology targets.
- Potential for an improved therapeutic window by minimizing off-target exposure.
- The global radiopharmaceutical market is growing rapidly, valued at US$8 billion and projected to reach US$15 billion by 2030.
- The patent enhances Starpharma’s intellectual property and supports its strategy for multiple radiopharmaceutical programs.
- Starpharma is exploring partnerships in the radiopharmaceutical sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pivotal Metals Limited (PVT) ORDINARY FULLY PAID |
Materials |
$21 |
Drill Program Expanded at Belleterre
|
2 Jul 2026 9:20AM |
$0.011 |
$0.016 |
risen by
45.45%
|
|
PVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Pivotal Metals to expand drill program by 1,500m at Lorraine Mine East.
- Program targets magmatic sulphide and gold anomalies near past-producing Lorraine Mine.
- Initial 1,800m program extended; aims for new discoveries in Belleterre Projects, Québec.
- IP survey identified multiple high-priority drill targets.
- Belleterre Projects cover a 160 km2 area in a Tier-1 mining jurisdiction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,344 |
Acquisition Delivers High Value Critical Minerals
|
2 Jul 2026 9:19AM |
$4.320 |
$3.710 |
fallen by
14.12%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- IperionX completed the acquisition of the Camden site.
- The site contains high-grade critical mineral stockpiles.
- Camden is synergistic with the Titan Project in Tennessee.
- Historical operations have enriched the site's rare earth minerals.
- Existing infrastructure at Camden reduces CAPEX and risks.
- The acquisition enhances U.S. supply chain for critical minerals.
- IperionX will engage with U.S. government and strategic partners.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| C29 Metals Limited (C29) ORDINARY FULLY PAID |
Materials |
$3 |
Cancel - Proposed issue of securities - C29
|
2 Jul 2026 9:19AM |
$0.020 |
$0.015 |
fallen by
25%
|
|
| C29 Metals Limited (C29) ORDINARY FULLY PAID |
Materials |
$3 |
Update on Cancun Transaction and Capital Raising
|
2 Jul 2026 9:19AM |
$0.020 |
$0.015 |
fallen by
25%
|
|
C29 - Price-sensitive ASX Announcement
Full Release
Key Points
- Termination of the Acquisition Agreement with Cancun Gold Pty Ltd.
- Due diligence findings in Namibia were unsatisfactory.
- Cancellation of Tranche 2 of the capital raising initiative.
- Return of funds to Tranche 2 Placement Shares participants.
- Non-progression of certain security-related resolutions from the General Meeting.
- Focus on exploration opportunities within existing Australian assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Emmerson Resources Limited (ERM) ORDINARY FULLY PAID |
Materials |
$210 |
Removal from Official List
|
2 Jul 2026 9:18AM |
$0.305 |
$0.305 |
fallen by
0%
|
|
| Fisher & Paykel Healthcare Corporation Limited (FPH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$19,428 |
Ongoing Disclosure Notice - Ordinary Shares
|
2 Jul 2026 9:18AM |
$31.810 |
$33.080 |
risen by
3.99%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$8,057 |
Change in substantial holding
|
2 Jul 2026 9:18AM |
$118.450 |
$123.200 |
risen by
4.01%
|
|
| Ordell Minerals Limited (ORD) ORDINARY FULLY PAID |
Materials |
$36 |
Extensive Gold Anomalism at Goodia and Fisher South Projects
|
2 Jul 2026 9:17AM |
$0.440 |
$0.520 |
risen by
18.18%
|
|
ORD - Price-sensitive ASX Announcement
Full Release
Key Points
- Extensive surface gold anomalies identified at Goodia and Fisher South Projects.
- First-pass air-core drilling planned at Goodia to test anomalies in September 2026.
- 59-hole air-core drilling completed at Fisher South, showing 14m @ 150ppb Au.
- Anomalous tungsten up to 1,700ppm discovered at Fisher South.
- Further exploration work includes sampling, data integration, and additional drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$97 |
Southern Cross Gold Project Update
|
2 Jul 2026 9:17AM |
$0.460 |
$0.445 |
fallen by
3.26%
|
|
GHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong intercepts along +3km Hopes Hill mineralised trend.
- High-grade gold findings in Hopes Hill Main: 8.0m @ 9.1 g/t Au from 124m, 4.4m @ 12.4 g/t Au from 234.5m.
- Planned infill drilling and deep diamond drilling to explore depth extents.
- 100km of RC and Diamond drilling completed since 2025.
- Submission of two Mining Lease applications at Hopes Hill North.
- Anticipation of an inaugural Mineral Resource Estimate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patagonia Lithium Ltd (PL3) ORDINARY FULLY PAID |
Materials |
$28 |
Notice of 2026 General Meeting and Proxy Form
|
2 Jul 2026 9:17AM |
$0.090 |
$0.115 |
risen by
27.78%
|
|
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$13 |
Cleansing Notice
|
2 Jul 2026 9:16AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
| Savannah Goldfields Limited (SVG) ORDINARY FULLY PAID |
Materials |
$25 |
Significant Increase in Mineral Resource for Red Dam
|
2 Jul 2026 9:15AM |
$0.010 |
$0.011 |
risen by
10%
|
|
SVG - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant increase in Red Dam Mineral Resource: 396 kt at 4.6 g/t Au.
- 96% increase in tonnage and 59% increase in contained gold from 2022.
- First-time reporting of Indicated Mineral Resources: 68 kt at 7.9 g/t Au.
- Inferred Mineral Resources: 328 kt at 3.9 g/t Au.
- Located 80 km north of Georgetown Gold Processing Plant.
- Enhanced geological confidence from recent drilling.
- Exploration Target remains between 430 kt and 1,060 kt.
- Plans for further drilling in 2026 to expand the resource.
- Sulphide mineralization with high arsenic content.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fidelity Asia Active ETF (FASI) |
Financials |
$28 |
Final Distribution & Reinvestment Price - 30 June 2026
|
2 Jul 2026 9:15AM |
$11.670 |
$11.280 |
fallen by
3.34%
|
|
| Fidelity Global Future Leaders Active ETF (FCAP) |
Financials |
$7 |
Final Distribution & Reinvestment Price - 30 June 2026
|
2 Jul 2026 9:15AM |
$12.080 |
$11.890 |
fallen by
1.57%
|
|